AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity
Authors: Wuchter, C Krappmann, D Cai, Z Ruppert, V Scheidereit, C Dorken, B Ludwig, WD Karawajew, L
Citation: C. Wuchter et al., In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cellsin the context of TRAIL receptor gene expression and constitutive NF-kappaB activity, LEUKEMIA, 15(6), 2001, pp. 921-928
Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation
Authors: Cai, Z Lin, M Wuchter, C Ruppert, V Dorken, B Ludwig, WD Karawajew, L
Citation: Z. Cai et al., Apoptotic response to homoharringtonine in human wt p53 leukemic cells is independent of reactive oxygen species generation and implicates Bax translocation, mitochondrial cytochrome c release and caspase activation, LEUKEMIA, 15(4), 2001, pp. 567-574
Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping
Authors: Wuchter, C Ratei, R Spahn, G Schoch, C Harbott, J Schnittger, S Haferlach, T Creutzig, U Sperling, C Karawajew, L Ludwig, WD
Citation: C. Wuchter et al., Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping, HAEMATOLOG, 86(2), 2001, pp. 154-161
Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma
Authors: Martin-Subero, JI Siebert, R Harder, L Gesk, S Schwindt, P Brauninger, A Willenbrock, K Steinemann, D Tiemann, M Calasanz, MJ Grote, W Ludwig, WD Hansmann, ML Schlegelberger, B
Citation: Ji. Martin-subero et al., Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma, AM J HEMAT, 68(4), 2001, pp. 276-279
Remission induction therapy: the more intensive the better?
Authors: Buchner, T Hiddemann, W Berdel, W Wormann, B Loffler, H Schoch, C Haferlach, T Ludwig, WD Maschmeyer, G Staib, P Andreesen, R Balleisen, L Haase, D Eimermacher, H Aul, C Rasche, H Uhlig, J Gruneisen, A Reis, HE Hartlapp, J Hirschmann, WD Weh, HJ Pielken, HJ Gassmann, W Sauerland, MC Heinecke, A
Citation: T. Buchner et al., Remission induction therapy: the more intensive the better?, CANC CHEMOT, 48, 2001, pp. S41-S44
The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia
Authors: Fuchs, U Rehkamp, G Haas, OA Slany, R Konig, M Bojesen, S Bohle, RM Damm-Welk, C Ludwig, WD Harbott, J Borkhardt, A
Citation: U. Fuchs et al., The human formin-binding protein 17 (FBP17) interacts with sorting nexin, SNX2, and is an MLL-fusion partner in acute myelogeneous leukemia, P NAS US, 98(15), 2001, pp. 8756-8761
Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients
Authors: Bene, MC Bernier, M Casasnovas, RO Castoldi, G Doekharan, D van der Holt, B Knapp, W Lemez, P Ludwig, WD Matutes, E Orfao, A Schoch, C Sperling, C van't Veer, MB
Citation: Mc. Bene et al., Acute myeloid leukaemia MO: haematological, immunophenotypic and cytogenetic characteristics and their prognostic significance: an analysis in 241 patients, BR J HAEM, 113(3), 2001, pp. 737-745
Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2
Authors: Hilgenfeld, E Padilla-Nash, H McNeil, N Knutsen, T Montagna, C Tchinda, J Horst, J Ludwig, WD Serve, H Buchner, T Berdel, WE Schrock, E Ried, T
Citation: E. Hilgenfeld et al., Spectral karyotyping and fluorescence in situ hybridization detect novel chromosomal aberrations, a recurring involvement of chromosome 21 and amplification of the MYC oncogene in acute myeloid leukaemia M2, BR J HAEM, 113(2), 2001, pp. 305-317
Molecular characterization of the translocation (10;11)(p13;q14): MLL and CALM are fused to AF10 in morphologically different subsets of acute leukemia
Authors: Dreyling, MH Schrader, K Muschinsky, V Fonatsch, C Schlegelberger, B Haase, D Schoch, C Ludwig, WD Hiddemann, W Bohlander, SK
Citation: Mh. Dreyling et al., Molecular characterization of the translocation (10;11)(p13;q14): MLL and CALM are fused to AF10 in morphologically different subsets of acute leukemia, HEMAT BLOOD, 40, 2001, pp. 20-26
Involvement of BCL-2 and Bax in the IL-3-induced inhibition of spontaneousapoptosis in childhood T-ALL
Authors: Ruppert, V Wuchter, C Dorken, B Ludwig, WD Karawajew, L
Citation: V. Ruppert et al., Involvement of BCL-2 and Bax in the IL-3-induced inhibition of spontaneousapoptosis in childhood T-ALL, HEMAT BLOOD, 40, 2001, pp. 128-135
Modulation of AraC by fludarabine: Results of salvage therapy by AMLCG
Authors: Kern, W Matylis, A Gruneisen, T Huber, C Grote-Metke, A Wormann, B Buchner, T Ohnesorge, J Ludwig, WD Hiddemann, W
Citation: W. Kern et al., Modulation of AraC by fludarabine: Results of salvage therapy by AMLCG, HEMAT BLOOD, 40, 2001, pp. 201-209
Randomized comparison of sequential high-dose cytosine arabinoside and idarubicin (S-HAI) with or without chemo-modulation by fludarabine in refractory and relapsed acute myeloid leukemia
Authors: Kern, W Matylis, A Gruneisen, T Huber, C Grote-Metke, A Wormann, B Buchner, T Ohnesorge, J Ludwig, WD Hiddemann, W
Citation: W. Kern et al., Randomized comparison of sequential high-dose cytosine arabinoside and idarubicin (S-HAI) with or without chemo-modulation by fludarabine in refractory and relapsed acute myeloid leukemia, HEMAT BLOOD, 40, 2001, pp. 578-587
TT virus
Authors: Burger, R Gerlich, W Gurtler, L Heiden, M Hitzler, W Jansen, B Lefevre, H Lower, J Ludwig, WD Montag-Lessing, T Paessens, A Pauli, G Seitz, R Schlenkrich, U Werner, E Willkommen, H
Citation: R. Burger et al., TT virus, INFUS THER, 27(3), 2000, pp. 114-116
Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8
Authors: Ratei, R Matylis, A Krahl, D Arnold, R Stein, H Dorken, B Ludwig, WD
Citation: R. Ratei et al., Salvage therapy for relapsed mediastinal B-cell lymphoma with allogeneic HLA-identical related donor bone marrow transplantation, donor lymphocyte infusion and IDEC-C2B8, LEUK LYMPH, 40(1-2), 2000, pp. 133-140
Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?
Authors: Buchner, T Hiddemann, W Wormann, B Loffler, H Ludwig, WD Schoch, C Haferlach, T Maschmeyer, G Staib, P Aul, C Heyll, A Gruneisen, A Rasche, H Eimermacher, H Balleisen, L Pielken, HJ Reis, HE Griesinger, F Reichle, A Sauerland, MC Heinecke, A
Citation: T. Buchner et al., Acute myeloid leukemia in adults: Is postconsolidation maintenance therapynecessary?, INT J HEMAT, 72(3), 2000, pp. 285-289
Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
Authors: Gokbuget, N Hoelzer, D Arnold, R Bohme, A Bartram, CR Freund, M Ganser, A Kneba, M Langer, W Lipp, T Ludwig, WD Maschmeyer, G Rieder, H Thiel, E Weiss, A Messerer, D
Citation: N. Gokbuget et al., Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL), HEMAT ONCOL, 14(6), 2000, pp. 1307
Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo
Authors: Prokop, A Wieder, T Sturm, I Essmann, E Seeger, K Wuchter, C Ludwig, WD Henze, G Dorken, B Daniel, PT
Citation: A. Prokop et al., Relapse in childhood acute lymphoblastic leukemia is associated with a decrease of the Bax/Bcl-2 ratio and loss of spontaneous caspase-3 processing in vivo, LEUKEMIA, 14(9), 2000, pp. 1606-1613
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia
Authors: Lengfelder, E Reichert, A Schoch, C Haase, D Haferlach, T Loffler, H Staib, P Heyll, A Seifarth, W Saussele, S Fonatsch, C Gassmann, W Ludwig, WD Hochhaus, A Beelen, D Aul, C Sauerland, MC Heinecke, A Hehlmann, R Wormann, B Hiddemann, W Buchner, T
Citation: E. Lengfelder et al., Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia, LEUKEMIA, 14(8), 2000, pp. 1362-1370
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1
Authors: Wuchter, C Harbott, J Schoch, C Schnittger, S Borkhardt, A Karawajew, L Ratei, R Ruppert, V Haferlach, T Creutzig, U Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1, LEUKEMIA, 14(7), 2000, pp. 1232-1238
Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells
Authors: Kordes, U Krappmann, D Heissmeyer, V Ludwig, WD Scheidereit, C
Citation: U. Kordes et al., Transcription factor NF-kappa B is constitutively activated in acute lymphoblastic leukemia cells, LEUKEMIA, 14(3), 2000, pp. 399-402
Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life
Authors: Stanulla, M Kasper, B Schrappe, M Viehmann, S Harbott, J Ludwig, WD Welte, K
Citation: M. Stanulla et al., Granulocyte colony-stimulating factor receptor expression and 11q23/MLL genotype in childhood acute lymphoblastic leukemia developing during the first 18 months of life, LEUKEMIA, 14(2), 2000, pp. 337-338
Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995
Authors: Schrappe, M Reiter, A Zimmermann, M Harbott, J Ludwig, WD Henze, G Gadner, H Odenwald, E Riehm, H
Citation: M. Schrappe et al., Long-term results of four consecutive trials in childhood ALL performed bythe ALL-BFM study group from 1981 to 1995, LEUKEMIA, 14(12), 2000, pp. 2205-2222
Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients
Authors: Bohlander, SK Muschinsky, V Schrader, K Siebert, R Schlegelberger, B Harder, L Schemmel, V Fonatsch, C Ludwig, WD Hiddemann, W Dreyling, MH
Citation: Sk. Bohlander et al., Molecular analysis of the CALM/AF10 fusion: identical rearrangements in acute myeloid leukemia, acute lymphoblastic leukemia and malignant lymphoma patients, LEUKEMIA, 14(1), 2000, pp. 93-99
Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia
Authors: Wuchter, C Karawajew, L Ruppert, V Schrappe, M Buchner, T Schoch, C Haferlach, T Harbott, JN Ratei, R Dorken, B Ludwig, WD
Citation: C. Wuchter et al., Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia, HAEMATOLOG, 85(7), 2000, pp. 711-721
Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90
Authors: Neth, O Seidemann, K Jansen, P Mann, G Tiemann, M Ludwig, WD Riehm, H Reiter, A
Citation: O. Neth et al., Precursor B-cell lymphoblastic lymphoma in childhood and adolescence: Clinical features, treatment, and results in trials NHL-BFM 86 and 90, MED PED ONC, 35(1), 2000, pp. 20-27
Risultati: 1-25 | 26-42